We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00492895
First Posted: June 27, 2007
Last Update Posted: January 29, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Zurich
  Purpose
Photosensitivity of the skin to UVA and UVB will be determined

Condition Intervention Phase
Skin Cancer Drug: Discontinuation of Azathioprin Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Photosensitivity of the skin to UVA and UVB [ Time Frame: 2 years ]

Enrollment: 25
Study Start Date: June 2007
Study Completion Date: March 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A
one arm only. Crossover study
Drug: Discontinuation of Azathioprin
Discontinuation of Azathioprin

Detailed Description:

Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without azathioprine will be determined. Azathioprine will be discontinued and photosensitivity determined after a wash-out period of three months

  • Trial with medicinal product
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion criteria:

  • Renal transplant recipients under azathioprin

Exclusion criteria:

  • Treatment with Prograf (Tacrolimus)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00492895


Locations
Switzerland
Clinic for Dermatology, University Hospital of Zurich
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Günther Hofbauer, M.D UniversitaetsSpital Zuerich
  More Information

Publications:
Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT00492895     History of Changes
Other Study ID Numbers: 2007DR2040
First Submitted: June 19, 2007
First Posted: June 27, 2007
Last Update Posted: January 29, 2013
Last Verified: January 2013

Additional relevant MeSH terms:
Skin Neoplasms
Neoplasms by Site
Neoplasms
Skin Diseases